PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.84%
Revenue growth above 1.5x CSIQ's 24.15%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
74.47%
Gross profit growth above 1.5x CSIQ's 17.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
122.62%
EBIT growth above 1.5x CSIQ's 16.45%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
203.70%
Operating income growth above 1.5x CSIQ's 16.45%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
159.66%
Positive net income growth while CSIQ is negative. John Neff might see a big relative performance advantage.
160.00%
Positive EPS growth while CSIQ is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
164.29%
Positive diluted EPS growth while CSIQ is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.57%
Share reduction more than 1.5x CSIQ's 2.54%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.45%
Slight or no buyback while CSIQ is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
143.24%
OCF growth of 143.24% while CSIQ is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
88.10%
FCF growth of 88.10% while CSIQ is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
417.66%
10Y revenue/share CAGR under 50% of CSIQ's 8425.08%. Michael Burry would suspect a lasting competitive disadvantage.
417.66%
5Y revenue/share CAGR under 50% of CSIQ's 8425.08%. Michael Burry would suspect a significant competitive gap or product weakness.
417.66%
3Y revenue/share CAGR under 50% of CSIQ's 4405.82%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-65.03%
Negative 10Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-65.03%
Negative 5Y OCF/share CAGR while CSIQ is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-65.03%
Negative 3Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
209.07%
Below 50% of CSIQ's 2711.80%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
209.07%
Below 50% of CSIQ's 2711.80%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
209.07%
Below 50% of CSIQ's 976.74%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.49%
AR growth well above CSIQ's 17.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.41%
Inventory growth well above CSIQ's 11.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.04%
Asset growth well under 50% of CSIQ's 31.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
6.78%
Under 50% of CSIQ's 61.33%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
3.68%
R&D dropping or stable vs. CSIQ's 47.52%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
27.62%
SG&A growth well above CSIQ's 17.73%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.